布地奈德联合沙丁胺醇治疗小儿支气管哮喘疗效分析

Objective To investigate the effect of Budesonide combined with Salbutamol in treatment of chil-dren with bronchial asthma.Methods 100 cases of children with asthma were randomly divided into conventional therapy group(Group A)50 cases and combined treatment group(Group B)50 cases;Conventional therapy was given to group B and Group A Was givend the conventional therapy puls Budesonide combined with salbutamol treatment,2 times a day.The course of treatment was 10d;The effect of clinical symptom score、clinical recovery and adverse reac-tions in two groups were observed.Results The total efficiency of 47 cases(94.O%) in group A were significantly higher than the B group 36 cases(72.0%)(P<0.05);The index of breathing diffculties、coushing、wheezing、wheezing sustain and sleep satisfaction after treatment were significantly decreased compared with before treatment in two groups(all P<0.01);The time of recovery of breath shortness、cough、asthma、wheezing and therapy hys in group A were less than group B(all P<0.05).Condusion Atomizing inhalation treatment of Bedesonide combined with Sallbutamol was effective to treat children with bronchial asthma.     

布地奈德联合沙丁胺醇治疗小儿支气管哮喘疗效分析

Objective To investigate the effect of Budesonide combined with Salbutamol in treatment of chil-dren with bronchial asthma.Methods 100 cases of children with asthma were randomly divided into conventional therapy group(Group A)50 cases and combined treatment group(Group B)50 cases;Conventional therapy was given to group B and Group A Was givend the conventional therapy puls Budesonide combined with salbutamol treatment,2 times a day.The course of treatment was 10d;The effect of clinical symptom score、clinical recovery and adverse reac-tions in two groups were observed.Results The total efficiency of 47 cases(94.O%) in group A were significantly higher than the B group 36 cases(72.0%)(P<0.05);The index of breathing diffculties、coushing、wheezing、wheezing sustain and sleep satisfaction after treatment were significantly decreased compared with before treatment in two groups(all P<0.01);The time of recovery of breath shortness、cough、asthma、wheezing and therapy hys in group A were less than group B(all P<0.05).Condusion Atomizing inhalation treatment of Bedesonide combined with Sallbutamol was effective to treat children with bronchial asthma.     

33例SARS患者临床表现与治疗

OBJECTIVE: To investigate the clinical charactertistics and therapy of patients with SARS. METHODS:The cases of total 33 chinically diagnosed SARS patients admitted in Inner Mongolia Chest Hospital were analyzed retrospectively. RESULTS:The most common complaint is fever(in 100 percent of the patients). 33.3% of the cases suffered from dyspnea. The laboratory test abnormality happened in about half of cases, including leuknpenia, thrombocytopenia, elevated serum aminotrasferase, increasd cardio enzyme and glucose levels. The IgG artibody was detected in all tested 15 patients. The features of shadow in chest X-R are “soft”, “wet” and rapid change. 48.4% are severe. Corticosteroids were used in all the cases. 33.3% were treatcd by CPAP mechanical ventilation. 33.3% had basic diseases. 42% showed the inconsistency between the diagrams of temperature and pulse. The main complications are bone necrosis, pneumothorax,deterioration of tuberculosis, temporary increase of serum glucose and so on. CONCLUSION: SARS can result in damage of multi-organs. The most common symptoms are fever and respiratory system manifestations. In order to raise cure rate and lower mortality, it is important to command correctly the administration of corticosteroids and mechanical ventilation, treat carefully basic diseases and complications, provide sufficient nutrition, pay attention psychological therapy and daily life nursc.     

纤溶酶联合血塞通注射液治疗急性脑梗死临床研究

Objective To explore the total curative effects of Xuesaitong injection combined whth fibrinogenase on acute cerebral infarction(ACI). Methods One hundred and twelve patients with ACI were randomly and equally divided into two groups, 56 cases in the treatment group were treated with Xuesaitong injection combined Fibrinogenase, while 56 cases in the control group were treated with compound danshen injection, once a day for 15days. Results Coagulation indicators of the treatment group was obviously better than that of the control group(P ＜0.05 or P ＜ 0.01 ). The total effective rate (91.1% ) of the treatment group was obviously higher than that of the control group( 69.6% )( P＜ 0.05 ). The Neurological deficit scores of therapy group were significantly improved (P ＜ 0.05). There was no obvious adverse reaction. Conclusion Xuesaitong injection combined fibrinogenase are remarkablyeffective and safe in treating ACI.     

纤溶酶联合血塞通注射液治疗急性脑梗死临床研究

Objective To explore the total curative effects of Xuesaitong injection combined whth fibrinogenase on acute cerebral infarction(ACI). Methods One hundred and twelve patients with ACI were randomly and equally divided into two groups, 56 cases in the treatment group were treated with Xuesaitong injection combined Fibrinogenase, while 56 cases in the control group were treated with compound danshen injection, once a day for 15days. Results Coagulation indicators of the treatment group was obviously better than that of the control group(P ＜0.05 or P ＜ 0.01 ). The total effective rate (91.1% ) of the treatment group was obviously higher than that of the control group( 69.6% )( P＜ 0.05 ). The Neurological deficit scores of therapy group were significantly improved (P ＜ 0.05). There was no obvious adverse reaction. Conclusion Xuesaitong injection combined fibrinogenase are remarkablyeffective and safe in treating ACI.     

宫颈环形电切术治疗宫颈糜烂疗效观察

Objective To observe the clinical curative effect of cervical loop electrosurgical excision procedure in treatment of patients with cervical erosion by LEEP.Methods 268 patients whose cervical erosions were above Ⅱ°were treated by LEEP,and the length of operation time,bleeding volume in the operation, amount of vaginal discharge after the operation,the length of bleeding time and cervical repair were observed.Results Follow-up was 12 weeks.262 cases (97.76% ) were cured, 6 cases (2.24% ) were effective.The bleeding amount was less than 10ml.The average surgery time was(2.62 ±0.58) minutes.18 cases(6.71% ) had the colporrhagia.No infectious case was found.Conclusion The curative effect of LEEP for cervical erosion was significant,and operation was simple and safe.LEEP was a well treatment method of cervical erosion.     

支气管肺动脉成形术治疗中央型肺癌的临床分析

Objective The aim of this study is to review the surgical experience of bronchoplasty and pulmo-nary arterioplasty in treatment of central-type lung cancer. Methods From 2003 to 2005,36 cases of patients with central-type lung cancer underwent bronchoplasty and pulmonary arterioplasty. There were 28 males and 8 females with a mean age of 62 years. Accordlng to pTNM classification. 5 cases were in stage ⅡI B,and 27 in stage Ⅲ A and 4 in stage Ⅲ B. Histologically,there were 24 cases of squamous cell carcinoma,6 cases of adenocarcinoma,1 case of small cell lung cancer and 5 cases of adenesquamous carcinoma. Results No patients died in the perioperative peri-od. The overall 1-,3-, and 5-year survival rate were 74% (26/35) ,48% (11/23) and 33% (3/9) ,respectively.Conclusion The results suggest that bronchoplasty and pulmonary arterioplasty can decrease the proportions of total pneumonectomy and exploratory thoracetomy and expand the indication of operation. Bronchoplasty and pulmonary ar-terioplasty can be achieved with satisfactory outcome for central-type lung cancer,especially for those patients with ad-vanced lesions or poor pulmonary function.     

支气管肺动脉成形术治疗中央型肺癌的临床分析

Objective The aim of this study is to review the surgical experience of bronchoplasty and pulmo-nary arterioplasty in treatment of central-type lung cancer. Methods From 2003 to 2005,36 cases of patients with central-type lung cancer underwent bronchoplasty and pulmonary arterioplasty. There were 28 males and 8 females with a mean age of 62 years. Accordlng to pTNM classification. 5 cases were in stage ⅡI B,and 27 in stage Ⅲ A and 4 in stage Ⅲ B. Histologically,there were 24 cases of squamous cell carcinoma,6 cases of adenocarcinoma,1 case of small cell lung cancer and 5 cases of adenesquamous carcinoma. Results No patients died in the perioperative peri-od. The overall 1-,3-, and 5-year survival rate were 74% (26/35) ,48% (11/23) and 33% (3/9) ,respectively.Conclusion The results suggest that bronchoplasty and pulmonary arterioplasty can decrease the proportions of total pneumonectomy and exploratory thoracetomy and expand the indication of operation. Bronchoplasty and pulmonary ar-terioplasty can be achieved with satisfactory outcome for central-type lung cancer,especially for those patients with ad-vanced lesions or poor pulmonary function.     

支气管肺动脉成形术治疗中央型肺癌的临床分析

Objective The aim of this study is to review the surgical experience of bronchoplasty and pulmo-nary arterioplasty in treatment of central-type lung cancer. Methods From 2003 to 2005,36 cases of patients with central-type lung cancer underwent bronchoplasty and pulmonary arterioplasty. There were 28 males and 8 females with a mean age of 62 years. Accordlng to pTNM classification. 5 cases were in stage ⅡI B,and 27 in stage Ⅲ A and 4 in stage Ⅲ B. Histologically,there were 24 cases of squamous cell carcinoma,6 cases of adenocarcinoma,1 case of small cell lung cancer and 5 cases of adenesquamous carcinoma. Results No patients died in the perioperative peri-od. The overall 1-,3-, and 5-year survival rate were 74% (26/35) ,48% (11/23) and 33% (3/9) ,respectively.Conclusion The results suggest that bronchoplasty and pulmonary arterioplasty can decrease the proportions of total pneumonectomy and exploratory thoracetomy and expand the indication of operation. Bronchoplasty and pulmonary ar-terioplasty can be achieved with satisfactory outcome for central-type lung cancer,especially for those patients with ad-vanced lesions or poor pulmonary function.     

溶栓和抗凝方案治疗肺栓塞疗效分析

目的：尿激酶溶栓方案和低分子肝素抗凝方案治疗肺栓塞疗效的评价。方法：收集41名肺栓塞患者治疗资料，回顾性分析溶栓治疗和抗凝治疗的疗效，比较两组患者呼吸困难、胸痛等症状缓解率以及血气指标改善情况等。结果：与抗凝治疗组相比，溶栓治疗组患者呼吸困难、胸痛、咳嗽、咳血和紫绀缓解率均高于抗凝治疗组（P〈0．1），治疗有效率高于抗凝治疗组（P〈0．05）。结论：依本次实验结果可认为尿激酶溶栓治疗疗效优于低分子肝素抗凝治疗，     

超声诊断急性肺栓塞及溶栓疗效评价中的应用

目的探讨超声在诊断急性肺栓塞（PTE）及其对溶栓后疗效的评价。方法临床疑似PTE的35例患者进行超声心动图和下肢深静脉超声检查。经临床表现、心电图、超声、核素、螺旋CT、肺动脉造影综合检查后确诊的较大面积肺栓塞的25例接受溶栓抗凝治疗。比较溶栓前、溶栓后2周、溶栓后3个月心脏及下肢深静脉血栓的变化情况。结果超声心动图诊断PTE的直接征象（肺动脉血栓）2例,间接征象23例,无异常变化10例。溶栓后2周超声相关的主要监测指标（右室舒张末前后径RVEDD,右房舒张末上下径RADD,肺动脉主干内径MPA,肺动脉血流峰值速度VPA,肺动脉血流加速时间AT,三尖瓣反流峰值速度Vp,肺动脉收缩压PASP）与溶栓前参数比较明显好转（P〈0．05）,具有统计学意义。3个月后有8例超声的各项指标正常,其余与溶栓后2周的参数值比较无统计学差异。下肢深静脉检查18例32条血管内血栓。溶栓治疗后12例有效,管腔大部分再通,6例无效。结论超声诊断急性肺栓塞安全、无创、可靠,并且可作为溶栓疗效评价和长期随诊的工具。     

急性肺栓塞的溶栓治疗进展

急性肺栓塞是临床上具有较高发病率和死亡率的常见病,除抗凝外,溶栓治疗是一种有效的治疗方法;基于急性肺栓塞早期死亡风险进行危险分层,将急性肺栓塞患者分为高危、中危、低危三种状况并区别对待,对溶栓治疗有重要指导意义。     

肺血栓栓塞症应用溶栓与抗凝治疗的疗效比较

目的比较尿激酶溶栓方案和低分子肝素抗凝方案治疗肺栓塞的临床疗效。方法对48例PE患者的临床资料进行回顾性分析。结果溶栓组和抗凝组治疗后心率、呼吸频率均明显减慢,动脉血氧分压（PaO2）、动脉血二氧化碳分压（PaCO2）也均明显改善,但抗凝组不如溶栓组显著（P〈0.05）。溶栓组和抗凝组总有效率分别为96.2%、88.5%,两组总有效率比较,差异有显著性（P〈0.05）。结论尿激酶溶栓治疗疗效优于低分子肝素抗凝治疗。     

尿激酶静脉溶栓治疗急性肺栓塞(附30例临床分析)

目的 :观察尿激酶静脉溶栓治疗急性肺栓塞的疗效及安全性。方法 :将 30例急性肺栓塞患者随机分为 A、B两组。 A组 :于 2 h内静脉滴入生理盐水 10 0 m L +尿激酶 2万 U/ kg,同时应用低分子肝素钙 5 0 0 0 U、皮下注射每 12h1次 ,连用 7d,于停用低分子肝素钙前 3d开始服用华法令 ,华法令总疗程 6个月。 B组 :仅应用低分子肝素钙及华法令 ,应用方法同 A组。观察临床症状、体征及螺旋 CT检查的变化。结果 :尿激酶静脉溶栓治疗急性肺栓塞的总有效率为 75 % ,明显高于单纯抗凝治疗组的 2 0 % ,两者比较差异显著 (P<0 .0 1)。溶栓治疗组出血的发生率为 15 % ,且仅为皮肤粘膜的轻微出血 ,一般不需处理自行停止。与单纯抗凝组相比无显著差异 (P>0 .0 5 )。结论 :尿激酶静脉溶栓治疗急性肺栓塞疗效显著而又安全可靠 ,值得推广应用     

小剂量溶栓联合抗凝治疗急性次大面积肺血管栓塞效果观察

目的探讨小剂量溶栓联合抗凝治疗急性次大面积肺血管栓塞的临床效果。方法选择80例患者,随机分为两组,各40例,对照组使用阿替普酶,观察组则将对照组使用阿替普酶剂量减半进行,另外联合使用低分子肝素,比较两组患者肺动脉收缩压、右室内径及右房内径,并统计治疗期间发生的出血情况。结果观察组治疗后肺动脉收缩压显著低于对照组（P〈0．05）,且右室内径及右房内径小于对照组（P〈0．05）,观察组发生皮下出血的比率显著低于对照组,且未发生消化道出血和泌尿道出血。结论小剂量溶栓联合抗凝治疗急性次大面积肺血管栓塞能有效提高临床治疗效果,减少出血倾向,值得临床重视。     

肺血栓栓塞的临床治疗

目的探讨肺血栓栓塞症的临床特征、诊断和治疗,以提高其诊断率和治愈率。方法对45例确诊为肺血栓栓塞症患者的临床资料进行回顾性分析。结果41例抗凝治疗患者中有1例患者因病情进行性加重而死亡,其余患者均症状缓解后出院。4例溶栓治疗者中死亡1例,其余3例3d内症状缓解。结论肺血栓栓塞症临床表现缺乏特异性,易误诊,早期诊断至关重要,及时抗凝和溶栓治疗可提高治愈率。     

胸部创伤或开胸术后急性肺栓塞的早期诊断

目的 探讨胸部创伤或开胸术后急性肺栓塞的早期诊断经验.方法 对胸部创伤和开胸术后临床高度疑诊肺栓塞的9例患者,分别进行胸部X线摄片、螺旋CT血管造影、心电图检查、V/Q检查、D二聚体水平测定、动脉血气分析等各项检查并进行相关资料分析.结果 9例患者均获确诊,其中8例经溶栓治疗,1例经抗凝治疗,均获痊愈.结论 急性肺栓塞临床症状无特异性,螺旋CT肺动脉造影是肺栓塞安全、快捷、经济、敏感性高且特异性强的无创诊断方法.     

螺旋CT肺动脉造影对急性肺血栓栓塞症的诊断价值

目的评估螺旋CT肺动脉造影（SCTPA）在急性肺血栓栓塞症诊断的作用。方法回顾性分析43例急性肺栓塞患者螺旋CT肺动脉造影结果。结果43例患者795支肺动脉分支中254支发生栓塞（32％）,直接征象：部分性充盈缺损152处（60％）、完全性阻塞76处（30％）、轨道征8处（3％）、附壁血栓6处（2％）,灌注减低并密度不均12处（5％）;间接征象：肺动脉扩张13例（30％）、栓塞近端肺小动脉异常增粗6例（14％）、局部肺纹理稀疏、纤细22例（51％）、马赛克征3例（7％）、胸腔积液7例（16％）、肺不张7例（16％）、肺楔形变4例（9％）、磨玻璃影6例（14％）。结论SCTPA是诊断急性肺血栓栓塞症准确、简便、无创伤的有效方法。     

急性肺栓塞30例临床分析

报告我院确诊的３０例急性肺栓塞病人，其中合并深部静脉血栓１１例占３６．７％，原有心肺血管疾病者１２例占４０％，提示ＤＶＴ及心肺血管疾病是ＡＰＥ的重要易发危险因素。